|Articles|July 20, 2015

The Employee Profile in China R&D

Pharmaceutical companies are currently targeting the emerging markets of China and Africa for their future expansion, with the highest investment - USD 5.32 billion - just in China alone.

Pharmaceutical companies are currently targeting the emerging markets of China and Africa for their future expansion, with the highest investment - USD 5.32 billion - just in China alone. Mathini Ilancheran, Katherine Ni and Juanjo Cardona analyse recent recruitment patterns and talent profiles in this Applied Clinical Trials article.

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!

The Employee Profile in China R&D

Newsletter

Related Content

How Are Global Regulatory Agencies Adjusting Their Policies for Biosimilars?

When Borders Become Bottlenecks: How Pharma Should Adapt to the New Geopolitical Lens

Korea and Australia's P&MA Shift: From Local Launch Opportunities to Regional Blueprint

AstraZeneca Stock Becomes UK’s Biggest Stock

Basel, Switzerland, Puts Out Call for Pharma Execs

Trending on PharmExec

Lilly’s Orforglipron, Retatrutide Named as Defining GLP-1 Drugs of the Next Decade

Roundup: Pharma’s Funding Surge Ahead of J.P. Morgan 2026

Johnson & Johnson Reaches Agreement with Trump Administration, Continues $55 Billion US-Based Investment Plan

FDA Limits Regulations on Non-Medical Grade Wearable Fitness Devices

How is Re-Vana Using its Sustained-Delivery Hydrogel Technology to Position Itself as a Long-Term Partner at the 2026 J.P. Morgan Healthcare Conference?